✦ LIBER ✦

Double-blind controlled withdrawal of thioridazine treatment in elderly female inpatients with senile dementia

✍ Scribed by D. J. Findlay; J. Sharma; J. McEwen; B. R. Ballinger; W. J. MaClennan; A. M. McHarg

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 430 KB
Volume: 4
Category: Article
ISSN: 0885-6230
DOI: 10.1002/gps.930040210

No coin nor oath required. For personal study only.

✦ Synopsis

Thirty-six female inpatients with a clinical diagnosis of senile dementia, Alzheimer type, were entered into a doubleblind withdrawal of their established thioridazine. Over a four-week period there were no significant differences between the two study groups in terms of cognitive function, behaviour or physical state. There was no evidence of a withdrawal phenomenon and the use of replacement medication was at a similar low level in the two groups. Although significant differences were not established in terms of side-effects, there was a trend for greater reduction of these for the group in whom treatment was stopped. These data indicated that careful, controlled withdrawal of established thioridazine treatment is a safe procedure which may be useful in circumstances where the contribution of medication is unclear.

KEY wom-withdrawal, thioridazine, female inpatients, SDAT.

📜 SIMILAR VOLUMES

Zuclopenthixol and thioridazine in the t

Zuclopenthixol and thioridazine in the treatment of aggressive, elderly patients: A double-blind, controlled, multicentre study

✍ A. Harenko; I. Alanen; S. Elovaara; S. Ginström; U. Hagert; M. Savijärvi; A. Yli 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

A four-week double-blind study of zuclopenthixol and thioridazine in 64 elderly patients presenting with hostility or restlessness has been carried out in five Finnish mental hospitals. The ages of the patients in the two groups ranged from 64 to 97 years. The initial daily dose was 2-6 mg zuclopent

Venlafaxine versus nortriptyline in the

Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial

✍ Rob M. Kok; Willem A. Nolen; Thea J. Heeren 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa

A double-blind, placebo-controlled asses

A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression

✍ Rory L. Marraccini; Charles F. Reynolds III; Patricia R. Houck; Mark D. Miller; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

The authors assessed the severity of nortriptyline's side-effects in older patients with recurrent major depression during placebo-controlled, double-blind maintenance therapy. Data were from 37 patients completing 2-3 years of maintenance therapy; 29 were on nortriptyline and eight were on placebo.

Very early treatment with infliximab in

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

✍ Mark A. Quinn; Philip G. Conaghan; Philip J. O'Connor; Zunaid Karim; Adam Greens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views